Skin Cancer (Nonmelanoma)

Study Reveals Successful Results for Treatment of Cutaneous T-Cell Lymphoma
August 02, 2022

Soligenix announces positive phase 3 results from FLASH study for the use of synthetic hypericin to reduce cutaneous T-cell lymphoma lesions.

Mouse Model May Shed Light on APC mutations in brain metastases
August 02, 2022

A grant from the Melanoma Research Foundation powers the initial stages of the project.

Phase I/II Study of Topical Biologic Shows Positive Results for the Treatment of Basal Cell Carcinoma
July 20, 2022

MW005 treatment for low-risk basal cell carcinoma would offer patients an alternative to surgical excision.

Severe Hemorrhage from Infantile Hemangioma
July 18, 2022

A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.

POLL: Which is the Most Common Skin Condition in the US?
June 27, 2022

Click here to answer this week's poll.

POLL: What Percentage of Skin Aging is Caused by the Sun?
June 21, 2022

Click here to answer this week's poll.

Data Suggest Low Recurrence Rate of Nail SCC Treated with Mohs, Wide Surgical Excision
June 09, 2022

A systematic review of literature shows a shift from amputation to other surgical tactics to treat certain types of nail squamous cell carcinomas.

Age Is Not Sole Predictor of Post-Surgical Outcomes in Older Patients with BCC
June 09, 2022

Age alone does not appear to predict all post-treatment outcomes for BCC patients and should not be used solely to guide BCC-related treatment decisions, a recent study says.

Sanofi Sells Rights of Cemiplimab to Regeneron
June 02, 2022

Regeneron Pharmaceuticals Inc came to an agreement to buy the drug from Sanofi for up to $1.1 billion.

AAD Focused AK Update Recommends Topical Tirbanibulin
May 30, 2022

The AAD recently added topical tirbanibulin (Klisyri: Almirall) to its list of recommended therapies for treating AK.